Risk Factors, Prophylaxis, and Treatment of Venous Thromboembolism in Congenital Heart Disease Patients
Congenital heart disease (CHD) is a common condition in the pediatric population, affecting up to 1% of all live births (i.e., around 40,000 newborns/year in the United States). Although CHD does have a wide range of severity, by the age of 5 years approximately 80% of patients will require at least...
Saved in:
Main Authors: | Michael Silvey (Author), Leonardo R. Brandão (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2017-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Venous thromboembolism: Risk profile and management of prophylaxis in gynaecological surgery patients
by: Janine Potgieter, et al.
Published: (2014) -
Venous thromboembolism risks and prophylaxis in King Fahad Hospital, Madinah, Saudi Arabia
by: Ayman Kharaba, et al.
Published: (2019) -
A Survey of Venous Thromboembolism (VTE) Prophylaxis in Obstetrics Patients in Iran
by: Majid Mokhtari, et al.
Published: (2019) -
Risk factors for venous thromboembolism in women
by: Т. Н. Тутченко, et al.
Published: (2018) -
Prophylaxis and management of venous thromboembolism during pregnancy and postpartum period
by: V. Ya. Khryshchanovich, et al.
Published: (2021)